Gene · 51514
Papers1,470
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,470
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network-based insights into miR-30a-5p-mediated regulation and EGCG targeting in triple-negative breast cancer. | Front Bioinform | 2025 | 41487287 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. | Front Immunol | 2025 | 41409301 | PubTator, text mining | PubMed |
| Identification of key candidate genes for ovarian cancer using integrated statistical and machine learning approaches. | Brief Bioinform | 2025 | 41405958 | PubTator, text mining | PubMed |
| Investigation of drivers' visual attributes in highway entrance zones utilizing Self-Organizing Mapping neural network. | Sci Rep | 2025 | 41326458 | PubTator, text mining | PubMed |
| Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors. | World J Gastrointest Oncol | 2025 | 41281471 | PubTator, text mining | PubMed |
| DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. | Int J Biol Macromol | 2025 | 41203163 | PubTator, text mining | PubMed |
| Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status. | Open Life Sci | 2025 | 41079598 | PubTator, text mining | PubMed |
| Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation. | Structure | 2025 | 41045927 | PubTator, text mining | PubMed |
| Computational prediction of diagnostic biomarker candidates and prognostic gene signature from DNA replication-related genes in breast cancer. | Discov Oncol | 2025 | 41003934 | PubTator, text mining | PubMed |
| Molecular and Genetic Markers for Malignant Melanoma: Implications for Prognosis and Therapy. | Dermatopathology (Basel) | 2025 | 40981345 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes. | Reprod Sci | 2025 | 40908400 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic and m6A Epitranscriptomic Analysis Reveals Colchicine-Induced Kidney Toxicity via DNA Damage and Autophagy in HK2 Cells. | Toxins (Basel) | 2025 | 40864084 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screening identifies SUV39H2 as a key regulator of oHSV-1 resistance in oral squamous cell carcinoma. | Cell Death Discov | 2025 | 40849299 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Identification of Novel Molecular Panel as Potential Biomarkers of PAN-Gastrointestinal Cancer Screening: Bioinformatics and Experimental Analysis. | Biology (Basel) | 2025 | 40723362 | PubTator, text mining | PubMed |
| Author Correction: DTL promotes the growth and migration of melanoma cells through the ERK/E2F1/BUB1 axis. | Sci Rep | 2025 | 40702100 | PubTator, text mining | PubMed |
| The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells. | Neoplasia | 2025 | 40680432 | PubTator, text mining | PubMed |
| Revealing the significance of tissue-resident memory T cells in lung adenocarcinoma through bioinformatic analysis and experimental validation. | Front Immunol | 2025 | 40642061 | PubTator, text mining | PubMed |
| DTL dose-dependent control of sex-dimorphic ferroptosis in liver ischemia reperfusion injury. | Cell Rep | 2025 | 40560731 | PubTator, text mining | PubMed |
| Gastrodin regulates H3K14la through the CDT2-KAT2A axis to treat Sepsis-induced myocardial dysfunction. | Int Immunopharmacol | 2025 | 40532326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51514/papers?page=2